Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001723128-19-000038

Director sold 23,345 shares at $12.39 ($289,245)

  • Director acquired 45,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

TERRERI PETER R · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-06 Sale : show line 1 in the form −23,345 $12.39 $289,245 25,192 D
2019-03-06 Exercise or conversion : show line 2 in the form +45,000 $6.55 $294,750 70,192 D
Open-market sales · 23,345 sh · avg $12.39 · $289,245

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-06 Exercise or conversion : show line 3 in the form Stock Option −45,000 0 D
Loading xslF345X03/wf-form4_155199847854964.xml…